StemCell Institute Inc. (7096.T)
JPY 1286.0
(-7.28%)
JPY 1286.0
(-7.28%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 42.26 Million JPY | 7.39% |
| 2022 | 39.35 Million JPY | -1.99% |
| 2021 | 40.14 Million JPY | 25.01% |
| 2020 | 32.11 Million JPY | 100.73% |
| 2019 | 16 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 37 Million JPY | -12.45% |
| 2023 Q4 | 42.26 Million JPY | 5.81% |
| 2023 Q3 | 39.94 Million JPY | 21.34% |
| 2023 Q2 | 32.91 Million JPY | 0.32% |
| 2023 Q1 | 32.81 Million JPY | -16.62% |
| 2023 FY | 42.26 Million JPY | 7.39% |
| 2022 Q3 | 33.85 Million JPY | 15.06% |
| 2022 Q2 | 29.42 Million JPY | 0.0% |
| 2022 Q4 | 39.35 Million JPY | 16.23% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 93.812% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -135.719% |
| GNI Group Ltd. | 2.33 Billion JPY | 98.187% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 98.103% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 37.372% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 96.23% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 59.181% |
| AnGes, Inc. | 1.61 Billion JPY | 97.384% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 42.888% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 98.544% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 86.872% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -22868.478% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 69.843% |
| CanBas Co., Ltd. | 728 Thousand JPY | -5705.22% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 51.9% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 71.433% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 34.076% |
| Kidswell Bio Corporation | 875.65 Million JPY | 95.174% |
| PeptiDream Inc. | 2.4 Billion JPY | 98.242% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -691.127% |
| Ribomic Inc. | 2.27 Million JPY | -1758.487% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -4226199900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -17.394% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -45.731% |
| CellSource Co., Ltd. | 305.92 Million JPY | 86.186% |
| FunPep Company Limited | 25.54 Million JPY | -65.467% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 88.391% |
| Stella Pharma Corporation | 1.11 Billion JPY | 96.214% |
| TMS Co., Ltd. | 50.02 Million JPY | 15.518% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -102.201% |
| Cuorips Inc. | 1.04 Million JPY | -3951.965% |
| K Pharma,Inc. | 10.79 Million JPY | -291.532% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.643% |
| ReproCELL Incorporated | 248.14 Million JPY | 82.968% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 90.621% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 81.51% |
| CellSeed Inc. | 46.19 Million JPY | 8.506% |